Quick Answer
TriSalus Life Sciences, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $45.15 million for the year ending 2025.
- TriSalus Life Sciences, Inc. showed an increase of +53.4% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from TriSalus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), TriSalus Life Sciences, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 264.2%.
- Historical annual values: Fiscal year 2025: $45.15 million | Fiscal year 2024: $29.43 million | Fiscal year 2023: $18.51 million | Fiscal year 2022: $12.40 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: